ALPHAMAB-B (09966) announced that on April 23, 2026, the company resolved to grant a total of 250,000 award shares to two eligible participants under the Restricted Share Award Plan. The participants are employees of the group. The award shares entitle the recipients to subscribe for up to 250,000 ordinary shares of the company, each with a par value of USD 0.000002. The grant is subject to acceptance by the award recipients.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.